肾细胞癌骨转移的临床与病理分析

doi:10.19723/j.issn.1671-167X.2018.05.008

摘要/Abstract

摘要： 目的：分析肾细胞癌骨转移（renal cell carcinoma bone metastasis，RCC-BM）的临床及病理学特点，进一步了解其发生、发展规律。方法：回顾2003年7月至2017年11月间RCCBM患者的资料，包括患者一般情况，临床与影像学特征，病理学亚型、骨转移灶免疫组织化学染色结果等病理学特征，进行描述性分析和差异性分析。结果：共纳入113例RCC-BM患者进入研究，患者性别比（男 ∶女）约为4 ∶1，平均年龄59.39岁。肾癌骨转移灶影像学均表现为溶骨性破坏，常见的骨转移部位为脊柱（46.0%）及骨盆（38.9%）， 28.3%的RCC-BM患者同时合并其他部位远处转移，46.0%的患者表现为同时性转移［骨转移时间（time to bone metastasis, TTBM）=0］，其余表现为异时性转移（TTBM>0），异时性转移患者的中位TTBM为48个月。113例患者中94.7%为肾透明细胞癌骨转移。对104例患者的骨转移病灶进行免疫组织化学染色检查，同时性RCC-BM患者骨转移灶的血管内皮生长因子（vascular endothelial growth factor，VEGF）阳性率与异时性RCC-BM患者相比有升高趋势（P=0.097），碳酸酐酶（carbo-nic anhydrase, CA）-Ⅸ阳性率有降低趋势（P=0.100）；肾透明细胞癌骨转移灶的表皮生长因子受体（epidermal growth factor receptor, EGFR）阳性率显著高于非透明细胞肾癌的骨转移灶（P<0.05）。结论：RCCBM中男性、中青年患者较多，约80%骨转移发生于脊柱、骨盆等中轴骨部位。不同TTBM亚组间CA-Ⅸ阳性率存在一定差异，可预测RCC-BM预后。VEGF阳性率在同时性RCC-BM亚组中有增高趋势，EGFR阳性率在透明细胞癌亚组中显著增高，可能给RCC-BM的诊断、预后分析、靶向治疗抉择等提供参考。

关键词: 肾细胞癌, 肿瘤转移, 骨, 临床病理学

Abstract: Objective： To analyze the clinical and pathological characteristics of renal cell carcinoma bone metastasis (RCC-BM) patients. Methods: Data of RCC-BM patients from July 2003 to November 2017 were retrospectively reviewed. The patients’ baseline characteristics (age, gender), tumor characteristics ［specific sites of bone metastasis, time to bone metastasis (TTBM), imaging features of bone disease, coexistence of other metastasis］, as well as pathological features (histological classification of primary and bone metastasis, immunohistochemical stain results) were collected. Descriptive analysis and difference analysis were used. Results: A total of 113 RCC-BM patients were enrolled with the gender ratio (male ∶female) of 4 ∶1, mean age of 59.39 years, and all present of osteolysis bone lesions. The common sites of bone metastasis were vertebra (46.0%) and pelvis (38.9%). Other distant metastasis sites coexisted in 28.3%, while 48.18% RCC-BM patients presented with synchronous metastasis (TTBM=0). The median TTBM for metachronous metastasis was 48 months. The majority in this cohort were determined to have primary tumor of clear cell carcinoma. After immunohistochemical examination to 104 RCC-BM patients and sub-group analysis, tendencies of higher positive rates of vascular endothelial growth factor (VEGF) was also found in synchronous group (P=0.097) while tendencies of higher positive rates of carbonic anhydrase (CA)-Ⅸ was found in the same group (P=0.100). The patients with clear cell RCC-BM had a significantly higher positive expression of epithelial growth factor receptor (EGFR, P<0.05) than those with non-clear cell RCC-BM group. Conclusion: More male and younger patients with metastatic lesions in axial skeleton were found in this cohort. Tendencies in the expression of CA-Ⅸ and VEGF in different TTBM sub-group and EGFR in different histology-derived subgroup indicate that they might be associated with risk and prognostic factors and support further target therapies of RCC-BM.

Key words: Renal cell carcinoma, Neoplasm metastasis, Bones, Clinical pathology

中图分类号:

R737.11

黄子雄，杜依青，张晓鹏，刘士军，徐涛. 肾细胞癌骨转移的临床与病理分析[J]. 北京大学学报(医学版), 2018, 50(5): 811-815.

HUANG Zi-xiong, DU Yi-qing, ZHANG Xiao-peng, LIU Shi-jun, XU Tao. Clinical and pathological analysis of renal cell carcinoma bone metastasis[J]. Journal of Peking University(Health Sciences), 2018, 50(5): 811-815.

参考文献

相关文章 15

[1]	刘园梅, 傅义程, 郝靖欣, 张福春, 刘慧琳. 老年髋部骨折患者住院期间发生术后心力衰竭的列线图预测模型的构建及验证[J]. 北京大学学报（医学版）, 2024, 56(5): 874-883.
[2]	汪琪伟, 包鹏宇, 洪士皓, 杨昕, 王宇, 曹永平. 改良股骨颈截骨术在伴严重屈曲畸形强直性脊柱炎患者手术治疗过程中的疗效[J]. 北京大学学报（医学版）, 2024, 56(5): 884-889.
[3]	周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T_3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报（医学版）, 2024, 56(4): 673-679.
[4]	李红光,韩玮华,吴训,冯继玲,李刚,孟娟红. 关节腔冲洗联合液态浓缩生长因子注射治疗单侧颞下颌关节骨关节炎的初步研究[J]. 北京大学学报（医学版）, 2024, 56(2): 338-344.
[5]	周颖,赵宁,黄竑远,李庆祥,郭传瑸,郭玉兴. 左侧三叉神经第三支带状疱疹并发左侧下颌骨骨坏死1例[J]. 北京大学学报（医学版）, 2024, 56(2): 366-370.
[6]	白心竹,何金徽,陆松松,李春,王依林,熊建. 椎体骨折合并活化部分凝血活酶时间延长1例[J]. 北京大学学报（医学版）, 2024, 56(2): 371-374.
[7]	毛渤淳,田雅婧,王雪东,李晶,周彦恒. 骨性Ⅱ类高角患者拔牙矫治前后的面部软硬组织变化[J]. 北京大学学报（医学版）, 2024, 56(1): 111-119.
[8]	陈晓颖,张一,李雨柯,唐琳,刘玉华. 不同种类聚合物对猪小肠黏膜下层支架仿生矿化的影响[J]. 北京大学学报（医学版）, 2024, 56(1): 17-24.
[9]	董佳芸,李雪芬,路瑞芳,胡文杰,孟焕新. 血管化骨瓣重建颌骨种植体周软组织病理学特点[J]. 北京大学学报（医学版）, 2024, 56(1): 25-31.
[10]	赵菡,卫彦,张学慧,杨小平,蔡晴,宁成云,徐明明,刘雯雯,黄颖,何颖,郭亚茹,江圣杰,白云洋,吴宇佳,郭雨思,郑晓娜,李文静,邓旭亮. 口腔硬组织修复材料仿生设计制备和临床转化[J]. 北京大学学报（医学版）, 2024, 56(1): 4-8.
[11]	周颖,赵宁,黄竑远,李庆祥,郭传瑸,郭玉兴. 双层软组织缝合封闭技术在下颌骨中早期药物相关性颌骨骨坏死患者手术治疗中的应用[J]. 北京大学学报（医学版）, 2024, 56(1): 51-56.
[12]	徐心雨,吴灵,宋凤岐,李自力,张益,刘筱菁. 基于下颌运动轨迹的正颌外科术中下颌骨髁突定位方法及初步精度验证[J]. 北京大学学报（医学版）, 2024, 56(1): 57-65.
[13]	王聪伟,高敏,于尧,章文博,彭歆. 游离腓骨瓣修复下颌骨缺损术后义齿修复的临床分析[J]. 北京大学学报（医学版）, 2024, 56(1): 66-73.
[14]	潘媛,顾航,肖涵,赵笠君,汤祎熳,葛雯姝. 泛素特异性蛋白酶42调节人脂肪干细胞成骨向分化[J]. 北京大学学报（医学版）, 2024, 56(1): 9-16.
[15]	刘晓强,周寅. 牙种植同期植骨术围术期高血压的相关危险因素[J]. 北京大学学报（医学版）, 2024, 56(1): 93-98.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed